Advertisement

Topics

CureVac GmbH Company Profile

18:50 EDT 22nd June 2018 | BioPortfolio

We are dedicated to offering reliable and innovative RNA related products and services to the Life Science Community. siRNA [order here]: ultrapure (HPLC purified)
For the design of siRNA please use EMBOSS.


Oligonucleotides [order here]: Customized small and large scale production, modifications, and labelling (HPLC purified)


RNActive™ [info] stabilized mRNA for enhanced gene expression:
Custom tailored RNActive™ purified by our proprietary chromatography technology PUREmessenger™

Location

Paul-Ehrlich-Str. 15
Tübingen
72076
Germany

Contact

Phone: 49 - 70 71 - 9 20 53 - 0
Fax: 49 - 70 71 - 9 20 53 - 11


News Articles [162 Associated News Articles listed on BioPortfolio]

CureVac to Pursue mRNA Vaccines Against Flu and Malaria

CureVac AG announced the awarding of two new grants from the Bill & Melinda Gates Foundation. The programs will leverage CureVac’s RNActive® prophylactic vaccine technology to develop mRNA-based va...

Bill & Melinda Gates Foundation shows faith in CureVac

The Bill & Melina Gates Foundation had already invested $52 million in CureVac, back in 2015, and has now doubled down on its investment, as the biotech announced that the foundation had boosted i...

Germany's CureVac wins new vaccine funding from Gates Foundation

(Reuters) - German biotech firm CureVac has secured more financial backing for vaccine development projects from its investor the Bill & Melinda Gates Foundation, working on jabs to prevent malaria an...

Bill Gates foundation awards grants to mRNA vaccine developer CureVac

CureVac, a biopharmaceutical company focused on developing mRNA-based drugs, has been awarded two new grants from the Bill & Melinda Gates Foundation.

CureVac and Arcturus Therapeutics announce broad strategic collaboration

CureVac AG and Arcturus Therapeutics Ltd. announced they have entered into a broad strategic collaboration to jointly discover, develop and commercialize novel messenger RNA (mRNA) therapeutics. Under...

CureVac and Arcturus Collaborate to Advance Next Generation of Lipid-Mediated mRNA Therapeutics

TÜBINGEN, Germany & BOSTON & SAN DIEGO–(BUSINESS WIRE)–CureVac AG, a leading clinical-stage biopharmaceutical company focused on the development of pioneering mRNA therapeutics, a...

Gates-Stiftung gibt neue Finanzspritze: Microsoft-Gründer Bill Gates will mit der Biotechfirma Curevac ...

Microsoft-Gründer Bill Gates will mit der Biotechfirma Curevac Impfstoffe gegen Malaria und Grippe entwickeln. Jetzt gibt er das dazu nötige Kapital.Der Microsoft-Gründer Bill Gates steckt weiteres...

CureVac Receives U.S. Patent Covering Entire Process for Pharmaceutical Manufacturing of RNA

CureVac AG, a fully-integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that the U.S. Patent and Trademark Office has issued a Notice of...

PubMed Articles [14 Associated PubMed Articles listed on BioPortfolio]

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

Postoperative Corneal Asphericity in Low, Moderate, and High Myopic Eyes After Transepithelial PRK Using a New Pulse Allocation.

To evaluate the postoperative asphericity in low, moderate, and high myopic eyes after combined transepithelial photorefractive keratectomy and SmartSurfACE treatment (SCHWIND eye-tech-solutions GmbH,...

Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder.

Photodynamic diagnosis using the optical imaging agent hexaminolevulinate (HAL, Hexvix®, Ipsen Pharma GmbH, Ettlingen, Germany) as an adjunct to white light cystoscopy (WLC) during the initial transu...

Clinical Trials [44 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Telemedical Examination of a Three-Component Oculomotor Testing Battery

The study investigates the feasibility and safety of the telemedical implementation of three diagnostic oculomotor tests using a video-oculography device and an extended teleconferencing s...

Companies [533 Associated Companies listed on BioPortfolio]

CureVac AG

CureVac is a leading company in the field of messenger RNA (mRNA) technology with more than 17 years’ expertise in handling and optimizing this versatile molecule for medical...

CureVac GmbH

We are dedicated to offering reliable and innovative RNA related products and services to the Life Science Community. siRNA [order here]: ultrapure (HPLC purified)For the design of siRNA please use EM...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

More Information about "CureVac GmbH" on BioPortfolio

We have published hundreds of CureVac GmbH news stories on BioPortfolio along with dozens of CureVac GmbH Clinical Trials and PubMed Articles about CureVac GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CureVac GmbH Companies in our database. You can also find out about relevant CureVac GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record